Embed Size (px)
Citation preview
421st OMICS International Conference
Cancer TherapyScientific Program
OMICS International Conferences:2360 Corporate Circle, Suite 400 Henderson, NV 89074-7722, USA
Ph: +1-888-843-8169, Fax: +1-650-618-1417, Toll free: +1-800-216-6499Email: [email protected], [email protected]
November 03-05, 2015 Valencia, Spain
8th Euro Global Summit on
Page 2
08:30-09:00 Registrations
Melia Meeting 1&2
Day 1 November 03, 2015
Networking & Refreshments 11:00-11:15 @ FoyerTrack 1: Advances in Cancer treatment and Biomarkers Track 2: Novel Approaches to Cancer Therapeutics and metabolomics Session Chair: Colleen Huber, Naturopathic Medical Doctors of Arizona, USASession Co-Chairs: Paolo Lombardi, Naxospharma srl Cesate, Italy
Session Introduction
11:15-11:40Title: Pharmacodynamic biomarkers in early phase Oncology trials: Opportunities and challengesSidath Katugampola, Centre for Drug Development Angel, UK
11:40-12:05Title: Effects of htlv-1 tax oncoprotein on brca1 expression and functionAmbali omotosho lukman, USA
12:05-12:30Title:Tentative application of middle gastrectomy in early gastric cancer in the Middle One-third of the StomachQin-Shu Shao, University of Miami, USA
12:30-12:55Title: Efficacy of imatinib in an extra-gastrointestinal stromal tumor presenting as a unilateral ovarian massAnn Meredith Uao Garcia, University of the Philippines, Philippines
12:55-13:20Title:Multi-Detector Computed Tomography (MDCT) Findings of Chemotherapy Induced Cardiopulmonary ChangesADEL EL-BADRAWY, Mansoura University, Egypt
Lunch Break 13:20-14:05 @ Aqua
14:05-16:05Work shop: Nanomedcine for Cancer Vladimir P. Torchilin, Center for Translational Cancer Nanomedicine, USA
16:20-16:55Title: Novel preclinical study of cancer targeting oncolytic adenoviruses co-expressing ING4 and TRAIL genes for treatment of Hepatocelluar CarcinomaAdel Galal El-Shemi, Umm Al-Qura University, Saudi Arabia
16:55-17:20Title: Current concepts and future of salivary markers for diagnosing oral squamous cell carcinoma: A review and analysis of relevant published studiesEsam Omar, Taibah University, Saudi Arabia
17:20-17:45Title: The application of precision liver resection in the treatment of hepatocellular CarcinomaPang Ting, Anhui provincial hospital, China
17:45-18:10Title: Tumor suppressive effect driven by cytoplasmic RNA-mediated innate signalingAkinori Takaoka, Hokkaido University, Japan
Panel Discussion
Opening Ceremony09:00- 09:25
Scientific Program
Keynote Forum09:25-09:30 Introduction
09:30-10:00 Colleen Huber Naturopathic Medical Doctors of Arizona, USA10:00-10:30 Xiaoming Yang University of Washington School of Medicine, USA10:30-11:00 Vladimir P Torchilin Center for Translational Cancer Nanomedicine, USA
Page 3
Day 2 November 04, 2015Melia Meeting 1&2
Keynote Forum10:00-10:30 Josef Bodor Institute of Hematology and Blood Transfusion, Czech Republic10:30-11:00 Paolo Lombardi Naxospharma srl Cesate, Italy11:00-11:30 Doron Margalit NEGBA, Israel
Networking & Refreshments 11:30-11:45 @ FoyerTrack 3: Advancement in Cancer Therapy Track 4: Cancer immunobiology, immunotherapy and Stem Cell Therapy Session Chair: Vladimir P. Torchilin, Center for Translational Cancer Nanomedicine, USASession Co-Chair: Helene Castel, University of Rouen, UK
Session Introduction
11:45-12:10Title: Toxicity assessment and ensuring compliance to oral chemotherapy with a pharmacist-run medication therapy management clinicJenna M Carmichael, Geisinger Health System, USA
12:10-12:35Title: Vasoactive peptide urotensin II as a new chemokine exhibiting migration/adhesion mesenchymal properties during glioma development: New therapeutic targetHélène Castel, University of Rouen, uk
12:35-13:00Title: Awareness and attitude of female university students towards Breast Self Examination Einass elshikh, Portsaid university, Egypt
Lunch Break 13:00-13:45 @ Aqua
13:45-14:45Workshop : Healing cancer patients using expressive therapyDoron Margalit, NEGBA, Israel
14:45-15:10Title: Tobacco consumption in Egypt …Enough Evidence, Increasing Prevalence!!Ghada Radwan, Cairo University, Egypt
15:10-15:35Title: Prognostic surrogate markers for survival, a case series for a novel antiangiogenic therapy ( Multitargeted Epigenetic therapies/MTET)M.A.Nezami, Pacific Medical Center of Hope, USA
15:35-16:00Title:The pivotal role of H19 in human tumorigenesis - Novel approach in cancer therapy Abraham Hochberg, The Hebrew University of Jerusalem, Israel
Networking & Refreshments 16:00-16:15 @ Foyer
16:15-16:35Title: Can adjuvant therapy with antidepressant drugs influence on glioblastoma multiforme stemcell population? In vitro studiesAnna Bielecka, Medical University of Silesias, Polska
16:35-17:00Title: Treatment of advanced gastrointestinal cancer in a clinical phase I/II trial with genetically modified mesenchymal stem cells: A Phase-I clinical studyChristine Guenther, Apceth GmbH and Co. KG, Germany
17:00-17:25Title: The role of topoisomerase [IIA] as a predictive factor for response to neoadjuvant anthracyclines based chemotherapy in locally advanced breast cancerMohamed Gamea, Gharbia Cancer Society, Egypt
17:25-17:50Title: Protocol to suppress cancer: Treatment time with hydro-soluble carotene in algorithm T=D/VJ A Garcia Urbina, Universidad Autónoma de Baja California Sur (UABCS), Mexico
17:50-18:15Title: Laboratory diagnosis & molecular characterization of bacterial bloodstream infections in pediatric cancer patients with feverRefaat A Sadek, Zagazig University, Egypt
Panel Discussion Poster Presentations 16:30 -17:30 @ foyer
Day 3 November 05, 2015Melia Meeting 1&2
Track 5: Cancer–Basic and Applied Research Track 6: Organ-Specific, Cancer Genetics Track 7: Anti-cancer drug deliverySession Chair: Akinori Takaoka, Hokkaido University, Japan
Session Introduction
10:00-10:25Title: Cross-talk between two antioxidants, thioredoxin reductase 1 and heme oxygenase-1 and therapeutic implications in multiple myelomaPrahlad V Raninga, Griffith University, Australia
10:25-10:50Title: The CCCTC binding factor (CTCF) may not directly regulate ERα mRNA expression in the ER+ MCF7 breast cancer cell lineOkezie Ofor, Anglia Ruskin University, UK
10:50-11:15Title: Systematic Identification and Characterization of the Methylproteome for Cancer InterventionShawn S.C. Li, Western University, Canada
Networking & Refreshments 11:15-11:30 @ Foyer
11:30-11:55Title: Dissection of Level I Cervical Lymph Nodes in Patients with Papillary Thyroid CarcinomaMahmoud F Sakr, University of Alexandria, Egypt
11:55-12:20Title: Factor predicting total nucleated cells count (TNC) in cord blood units Sarah Ali Alhedaithi, King Saud bin Abdulaziz University for Health Sciences, Riyadh
Lunch Break 12:20-13:05 @ AquaClosing & Award ceremony
OMICS Group Inc.2360 Corporate Circle, Suite 400Henderson, NV 89074-7722, USA
Ph: +1-888-843-8169Fax: +1-650-618-1417
OMICS International5716 Corsa Ave., Suite 110, Westlake
Los Angeles, CA 91362-7354, USAPh: +1-650-268-9744Fax: +1-650-618-1414
OMICS GroupSEZ Unit, Building No. 20, 9th Floor
APIIC Layout, HITEC CityHyderabad-500081, Telangana, INDIA
Ph: 040-40131823, [email protected]
Toll freeUSA & Canada: +1-800-216-6499
Australia: +1-800-651-097Europe: 0805-080048
Bookmark your dates
September 26-28, 2016 London, UKCancer Therapy12th Euro Global Summit on
Website: http://cancer.global-summit.com/europe/e-mail: [email protected]; [email protected]
![On Katugampola Laplace transform2. Katugampola Laplace Transform Salim, T.O., et al [9] have introduced a new definition of Katugampola Fourier transform which finds very interesting](https://img.dokumen.tips/doc/110x75/60e6145525034327c5001e8a/on-katugampola-laplace-transform-2-katugampola-laplace-transform-salim-to-et.jpg)
